African American men have increased risk of prostate cancer

NewsGuard 100/100 Score

African American men have an increased risk of prostate cancer and are two times more likely than Caucasian American men to die from the disease. Despite recent questions about the overall usefulness of prostate-specific antigen (PSA) testing to detect prostate cancer, should PSA screening be used to detect early-stage disease to help save lives in this at-risk population? The controversy is explored in a Review article in Journal of Men's Health, a peer-reviewed publication from Mary Ann Liebert, Inc., publishers. The article is available free on the Journal of Men's Health website at http://www.liebertpub.com/jomh.

In the Review "PSA Screening for the African American Male: When and Why?" Tyler Luthringer, Ilija Aleksic, Vladimir Mouraviev, and David Albala, Associated Medical Professionals of NY, PLLC, and SUNY Upstate Medical University, Syracuse, support the American Urological Association's position that early detection of prostate cancer should include multiple parameters to assess personal risk. Together with their physicians, men should decide on an individualized approach to risk assessment and screening, which may include PSA testing and digital rectal examination.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
NCCN 2024 Annual Conference focuses on practical applications for improving cancer care